Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients

Clinical trial NCT01155778 · COMPLETED

Trial details

NCT number: NCT01155778
Sponsor: Shire
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mucopolysaccharidosis (MPS)

Start date: 2010-06-01
Primary completion: 2012-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.